Portman Square Capital LLP Boston Scientific Corp Transaction History
Portman Square Capital LLP
- $2.72 Billion
- Q2 2024
A detailed history of Portman Square Capital LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Portman Square Capital LLP holds 191,500 shares of BSX stock, worth $16 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
191,500Holding current value
$16 Million% of portfolio
0.54%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BSX
# of Institutions
1,448Shares Held
1.21BCall Options Held
8.14MPut Options Held
8.3M-
Vanguard Group Inc Valley Forge, PA130MShares$10.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$10.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA61.5MShares$5.12 Billion0.21% of portfolio
-
Primecap Management CO Pasadena, CA38MShares$3.16 Billion2.15% of portfolio
-
Wellington Management Group LLP Boston, MA32.1MShares$2.67 Billion0.45% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $119B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...